|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-2-17
|
|
pubmed:abstractText |
Recent debate has emerged regarding the cardiovascular safety of selective cyclooxygenase 2 inhibitors and the possible cardioprotective effect of naproxen sodium. We compared the rates of acute myocardial infarction (AMI) among elderly patients dispensed selective cyclooxygenase 2 inhibitors, naproxen, and nonselective nonnaproxen nonsteroidal anti-inflammatory drugs (NSAIDs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0003-9926
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
24
|
|
pubmed:volume |
163
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
481-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12588209-Aged,
pubmed-meshheading:12588209-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:12588209-Case-Control Studies,
pubmed-meshheading:12588209-Cyclooxygenase Inhibitors,
pubmed-meshheading:12588209-Female,
pubmed-meshheading:12588209-Humans,
pubmed-meshheading:12588209-Lactones,
pubmed-meshheading:12588209-Male,
pubmed-meshheading:12588209-Myocardial Infarction,
pubmed-meshheading:12588209-Naproxen,
pubmed-meshheading:12588209-Ontario,
pubmed-meshheading:12588209-Proportional Hazards Models,
pubmed-meshheading:12588209-Pyrazoles,
pubmed-meshheading:12588209-Retrospective Studies,
pubmed-meshheading:12588209-Risk Factors,
pubmed-meshheading:12588209-Sulfonamides,
pubmed-meshheading:12588209-Sulfones
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly.
|
|
pubmed:affiliation |
Institute for Clinical Evaluative Sciences, 2075 Bayview Ave-G215, Toronto, Ontario, Canada M4N 3M5. muhammad.mamdani@ices.on.ca
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
